Pharmacist oversight improves vancomycin safety and success rates in patients

Patients taking vancomycin often need careful monitoring to avoid kidney damage and ensure the drug works. This large review looked at 63 studies to see if a pharmacist helping with the process made a difference. The answer was a clear yes. When pharmacists managed the drug levels, patients had fewer cases of acute kidney injury. This serious side effect happens when the kidneys get hurt by the medicine. The review found that pharmacist involvement reduced this risk significantly compared to when no pharmacist was involved. The team also saw better success rates for the treatment overall. Patients were more likely to reach the right blood levels of the drug when a pharmacist guided the process. This meant the medicine worked better for more people. The studies also showed that doctors adjusted dosages more often when a pharmacist was on the team. These changes helped keep patients safe and healthy during their treatment. While the review did not report on hospital stay length or medication duration, the safety and effectiveness gains are important. The findings suggest that having a pharmacist involved in managing vancomycin is a smart move for patient care.